©The Author(s) 2024.
World J Stem Cells. Jun 26, 2024; 16(6): 641-655
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Table 1 Study group characteristics
| Characteristics | n | % | |
| Age (yr) | 21 | 1 | 16.7 |
| 22 | 1 | 16.7 | |
| 25 | 2 | 33.3 | |
| 26 | 1 | 16.7 | |
| 27 | 1 | 16.7 | |
| Sex | Female | 2 | 33.3 |
| Male | 4 | 66.7 | |
| Cause of spinal cord injury | Traffic accident | 6 | 100.0 |
| Comorbidity | None | 6 | 100.0 |
| Treatments before transplantation | Non-surgical | 2 | 33.3 |
| Decompressive craniectomy | 1 | 16.7 | |
| Acute subdural hematoma evacuation and ventriculoperitoneal shunt | 1 | 16.7 | |
| Decompressive craniectomy and ventriculoperitoneal shunt | 1 | 16.7 | |
| Ventriculoperitoneal shunt | 1 | 16.7 | |
| Duration between spinal cord injury and first transplantation | 6 months | 1 | 16.7 |
| 18 months | 1 | 16.7 | |
| 22 months | 1 | 16.7 | |
| 24 months | 2 | 33.3 | |
| 48 months | 1 | 16.7 | |
- Citation: Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655
- URL: https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i6.641